BIONEXUS GENE LAB CORP (BGLC)

US0906282076 - Common Stock

0.361  -0.1 (-21.64%)

Premarket: 0.3321 -0.03 (-8.01%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
9.26M9.77M10.93M13.36M11.39M
Cost Of Goods
8.01M8.44M9.67M11.10M9.67M
Gross Profit
1.25M1.33M1.26M2.27M1.72M
Operating Expenses
2.21M3.92M1.55M1.21M450.00K
Selling, General, and Administrative Expenses
3.52M4.41M1.73M1.28M1.33M
Operating Income
-964.44K-2.59M-290.00K1.05M1.27M
Interest Income/Expense
44.15K-13.93K-10.00K-10.00K-10.00K
Income Before Taxes
-920.29K-2.61M-300.00K1.04M1.26M
Income Tax
22.32K21.53K50.00K290.00K170.00K
Net Income
-942.61K-2.63M-360.00K750.00K1.09M
EBITDA
-869.73K-2.51M-200.00K1.14M1.36M
 
Per Share Data
EPS Diluted Total Ops
-0.04-0.17-0.020.050.13
 
Statistics
Gross Profit Margin
13.47%13.61%11.53%16.99%15.10%
Profit Margin
-10.18%-26.91%-3.29%5.61%9.57%
Operating Profit Margin
-10.42%-26.54%-2.65%7.86%11.15%

All data in USD

Charts